Trial intelligence / Profile preview

Perioperative effects of dexmedetomidine in ACDF under general anesthesia

PACTR202510879446766Phase 3Completed

Sponsor
anesthesia department. facylty of medicine meniudia university egypt
Start
Mar 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of dexmedetomidine (2 arms), sponsored by anesthesia department. facylty of medicine meniudia university egypt. Primary endpoint: Time to emergence from general anesthesia. Started Mar 2024; status: completed.

02

Drugs

dexmedetomidine

Beyond the preview

Go deeper on PACTR202510879446766.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202510879446766.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call